Published in Scand J Infect Dis on January 01, 1988
Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice. Infect Immun (1998) 1.32
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care (2007) 1.32
Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol (2004) 1.28
Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol (2004) 0.84
Treating acute cystitis with biodegradable micelle-encapsulated quercetin. Int J Nanomedicine (2012) 0.79
In vitro and in vivo effects of soluble, monovalent globotriose on bacterial attachment and colonization. Antimicrob Agents Chemother (2005) 0.77
Wagging the dog: antibiotic use and the emergence of resistance. J Gen Intern Med (1999) 0.75
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother (1977) 3.32
Resistance of Escherichia coli to penicillins. V. Physiological comparison of two isogenic strains, one with chromosomally and one with episomally mediated ampicillin resistance. J Bacteriol (1968) 2.27
Invasive group A streptococcal infections. N Engl J Med (1996) 2.16
Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet (1989) 2.11
Molecular model for elongation of the murein sacculus of Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.97
Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol (1977) 1.96
Colicin tolerance induced by ampicillin or mutation to ampicillin resistance in a strain of Escherichia coli K-12. J Bacteriol (1971) 1.96
Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis (1991) 1.75
Evidence for diffuse growth of the cylindrical portion of the Escherichia coli murein sacculus. J Bacteriol (1983) 1.71
Autolysis of Neisseria gonorrhoeae. J Bacteriol (1976) 1.65
Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol (2004) 1.62
Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology (1999) 1.61
Immunoprecipitating factors of vaccinia virus. Virology (1965) 1.60
Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J Bacteriol (1970) 1.52
Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J Bacteriol (1973) 1.49
Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study. Scand J Infect Dis (1996) 1.46
Correlation between surface and air counts of particles carrying aerobic bacteria in operating rooms with turbulent ventilation: an experimental study. J Hosp Infect (1999) 1.45
Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis (1976) 1.44
Changes in the composition of Escherichia coli murein as it ages during exponential growth. J Bacteriol (1983) 1.43
Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis (1992) 1.43
Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis (1994) 1.42
Expression of streptococcal plasmid-determined resistance to erythromycin and lincomycin in Escherichia coli. Mol Gen Genet (1981) 1.40
Penetration of antibiotics into the normal and diseased maxillary sinus mucosa. Scand J Infect Dis Suppl (1978) 1.39
Relation between nursing procedures, other local characteristics and transmission of enteric bacteria in neonatal wards. J Hosp Infect (1993) 1.39
Biochemical fingerprinting compared with ribotyping and pulsed-field gel electrophoresis of DNA for epidemiological typing of enterococci. J Clin Microbiol (1995) 1.38
Evidence for multisite growth of Escherichia coli murein involving concomitant endopeptidase and transpeptidase activities. J Bacteriol (1983) 1.38
Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol (1988) 1.36
Influence of combinations of oral bacteria on periapical tissues of monkeys. Scand J Dent Res (1982) 1.35
Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun (1994) 1.34
Case of apparent reinfection with rubella. Lancet (1970) 1.31
Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis (1996) 1.31
Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J Antimicrob Chemother (1989) 1.27
Streptococcal anti-group A precipitins in sera from patients with rheumatic arthritis and acute glomerulonephritis. Int Arch Allergy Appl Immunol (1970) 1.27
Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis (1998) 1.26
Time- and media-saving testing and identification of microorganisms by multipoint inoculation on undivided agar plates. J Clin Microbiol (1978) 1.25
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb Drug Resist (2003) 1.25
Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun (2000) 1.23
Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis (1993) 1.21
Density profile of group B streptococci, type III, and its possible relation to enhanced virulence. J Clin Microbiol (1987) 1.21
Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun (1994) 1.21
Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17
Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb Pathog (1988) 1.16
Amplification of sex repressor function of one fi-+ R-factor during anaerobic growth of Escherichia coli. J Bacteriol (1975) 1.13
Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis (1995) 1.12
An allelic variant of the chromosomal gene for class A beta-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob Agents Chemother (1997) 1.12
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect (2009) 1.12
Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10
Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl (1983) 1.10
Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis (1986) 1.09
Long-term antibiotic treatment of chronic bacterial prostatitis. Effect on bacterial flora. Br J Urol (1989) 1.09
In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol (1999) 1.08
Some clinical, immunological and bacteriological observations in a case of pyogenic arthritis due to bacteroides fragilis. Scand J Infect Dis (1975) 1.08
Can decreased phagocytosis and killing of autologous gram-positive bacteria explain the finding of gram-positive bacteria in "non-bacterial prostatitis"? Acta Pathol Microbiol Immunol Scand B (1987) 1.07
Molecular cloning in streptococci: physical mapping of the vehicle plasmid pSM10 and demonstration of intergroup DNA transfer. Mol Gen Genet (1981) 1.06
An antigenic relationship between kidney and certain Escherichia coli strains. Int Arch Allergy Appl Immunol (1971) 1.06
Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl (1978) 1.05
The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care (1997) 1.04
Reevaluation of experiments intended to demonstrate immunological cross-reactions between mammalian tissues and streptococci. Prog Allergy (1979) 1.04
R-plasmid transfer and its response to nalidixic acid. J Bacteriol (1977) 1.04
A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate. Anal Biochem (1989) 1.03
Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.02
In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother (1981) 1.01
Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol (1999) 1.00
The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care (1998) 1.00
Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo. J Antimicrob Chemother (1990) 1.00
The role of household contacts in the transmission of group A streptococci. Scand J Infect Dis (1997) 1.00
Purification of immunolobulin G Fc-reactive factor from Streptococcus azgazardah. Acta Pathol Microbiol Scand C (1976) 1.00
Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli. J Med Microbiol (1992) 0.99
Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol (1992) 0.99
The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in Swedish neonatal wards. J Hosp Infect (1993) 0.98
Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J Infect Dis (1999) 0.97
Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect (1988) 0.97
Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child (2008) 0.97
Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131. Infect Immun (2000) 0.97
Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scand J Infect Dis (1981) 0.97
Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun (1998) 0.97
Demonstration and characterization of buoyant-density subpopulations of group B Streptococcus type III. J Infect Dis (1990) 0.96
Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward. Epidemiol Infect (1990) 0.96
An in vivo model for evaluation of the postantibiotic effect. Scand J Infect Dis (1988) 0.96
Nationwide spread of Klebsiella oxytoca K55 in Swedish neonatal special care wards. APMIS (1992) 0.93
Elongation of the murein sacculus of Escherichia coli. Ann Inst Pasteur Microbiol (1985) 0.93
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Epidemiology and ecology of enterococci, with special reference to antibiotic resistant strains, in animals, humans and the environment. Example of an ongoing project within the European research programme. Int J Antimicrob Agents (2000) 0.92
Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother (1987) 0.92
Small-fragment restriction endonuclease analysis in epidemiological mapping of group A streptococci. J Med Microbiol (1994) 0.92
Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Urol (1997) 0.91
Precipitinogens in beta-hemolytic streptococci and some related human kidney antigens. Acta Pathol Microbiol Scand (1967) 0.91
Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Results Cancer Res (1983) 0.91
Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile. J Hosp Infect (2003) 0.91
Expression of R-plasmid functions during anaerobic growth of an Escherichia coli K-12 host. J Bacteriol (1977) 0.90
A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol (2008) 0.90
Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (1999) 0.90